# Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis

> **NCT05012852** · NA · UNKNOWN · sponsor: **PepTonic Medical AB** · enrollment: 126 (estimated)

## Conditions studied

- Vaginal Candidiasis
- Vulvovaginal Candidiasis
- Candidal Vulvovaginitis

## Interventions

- **DEVICE:** VagiVitalAC

## Key facts

- **NCT ID:** NCT05012852
- **Lead sponsor:** PepTonic Medical AB
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-09
- **Primary completion:** 2022-02
- **Final completion:** 2022-06
- **Target enrollment:** 126 (ESTIMATED)
- **Last updated:** 2021-09-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05012852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05012852, "Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05012852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*